Bone, K. & Mills, S.,(2013). Principles and practice of phytotherapy (2nd ed.). Elsevier.
Chatterjee, S. S., Koch, E., Jaggy, H., & Krzeminski, T. (1997). In-vitro- und In-vivo-Untersuchungen zur kardioprotektiven Wirkung von oligomeren Procyanidinen in einem Crataegus-Extrakt aus Blättern mit Blüten [In vitro and in vivo studies on the cardioprotective action of oligomeric procyanidins in a Crataegus extract of leaves and blooms]. Arzneimittel-Forschung, 47(7), 821–825.
Graham J. D. (1939). Crataegus Oxyacantha in Hypertension. British medical journal, 2(4114), 951–953. https://doi.org/10.1136/bmj.2.4114.951
Hanus, M., Lafon, J., & Mathieu, M. (2004). Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders. Current medical research and opinion, 20(1), 63–71. https://doi.org/10.1185/030079903125002603
McIntyre, A. (2019). The complete herbal tutor. Aeon.
Schwinger, R. H., Pietsch, M., Frank, K., & Brixius, K. (2000). Crataegus special extract WS 1442 increases force of contraction in human myocardium cAMP-independently. Journal of cardiovascular pharmacology, 35(5), 700–707. https://doi.org/10.1097/00005344-200005000-00004
Ye, X. L., Huang, W. W., Chen, Z., Li, X. G., Li, P., Lan, P., Wang, L., Gao, Y., Zhao, Z. Q., & Chen, X. (2010). Synergetic effect and structure-activity relationship of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors from Crataegus pinnatifida Bge. Journal of agricultural and food chemistry, 58(5), 3132–3138. https://doi.org/10.1021/jf903337f